Mexico investigates drug sector for high prices

Mexico’s competition authority is probing potential anticompetitive agreements in the country’s pharmaceutical sector, including an acquisition named in the leaked Panama Papers, the agency announced on Wednesday.


Get unlimited access to all Latin Lawyer content